Literature DB >> 33577766

Skin-Homing Regulatory B Cells Required for Suppression of Cutaneous Inflammation.

Lazaro Emilio Aira1, Gudrun Fiona Debes2.   

Abstract

Pro and anti-inflammatory B-cell subsets that localize to unperturbed and inflamed skin are newly emerging components of the skin immune system. To test the relevance of regulatory B cells (Bregs) in the suppression of cutaneous inflammation, we asked whether impaired migration of these cells into the skin exacerbates skin inflammation. Using a mouse model with a B-cell‒specific tamoxifen-inducible deletion of α4β1 integrin, we demonstrate that selective disruption of α4β1-integrin expression in B cells significantly decreases IL-10+ Bregs in inflamed skin, whereas it does not affect their counterparts in lymphoid tissues. Impaired skin homing and reduced cutaneous accumulation of IL-10+ Bregs lead to a significant increase in clinical and histopathological parameters of inflammation in both psoriasiform skin inflammation and cutaneous delayed contact hypersensitivity. Thus, our data show a crucial function of skin-homing IL-10+ Bregs in the suppression of skin inflammation, supporting the notion that Bregs are critical players in the cutaneous environment during inflammatory skin diseases.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33577766      PMCID: PMC8316263          DOI: 10.1016/j.jid.2021.01.013

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   7.590


  51 in total

1.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

2.  Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8+ T Cells.

Authors:  Tadahiro Kobayashi; Kyosuke Oishi; Ai Okamura; Shintaro Maeda; Akito Komuro; Yasuhito Hamaguchi; Manabu Fujimoto; Kazuhiko Takehara; Takashi Matsushita
Journal:  J Invest Dermatol       Date:  2019-03-02       Impact factor: 8.551

Review 3.  Human regulatory B cells in health and disease: therapeutic potential.

Authors:  Claudia Mauri; Madhvi Menon
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.

Authors:  Simon Glatigny; Catriona A Wagner; Estelle Bettelli
Journal:  J Immunol       Date:  2016-03-25       Impact factor: 5.422

Review 5.  Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease.

Authors:  Ioannis Mitroulis; Vasileia I Alexaki; Ioannis Kourtzelis; Athanassios Ziogas; George Hajishengallis; Triantafyllos Chavakis
Journal:  Pharmacol Ther       Date:  2014-11-14       Impact factor: 12.310

Review 6.  Autoimmune Sequelae Following Rituximab Therapy: A Review of the Literature and Potential Immunologic Mechanisms.

Authors:  Anna E Kersh; Ron J Feldman
Journal:  J Clin Rheumatol       Date:  2018-12       Impact factor: 3.517

Review 7.  B-cell-directed therapy for inflammatory skin diseases.

Authors:  Angela Nagel; Michael Hertl; Rüdiger Eming
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

8.  VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P.

Authors:  K L Quinlan; I S Song; S M Naik; E L Letran; J E Olerud; N W Bunnett; C A Armstrong; S W Caughman; J C Ansel
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

9.  T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.

Authors:  Axel Roers; Lisa Siewe; Elke Strittmatter; Martina Deckert; Dirk Schlüter; Werner Stenzel; Achim D Gruber; Thomas Krieg; Klaus Rajewsky; Werner Müller
Journal:  J Exp Med       Date:  2004-11-08       Impact factor: 14.307

10.  CNS accumulation of regulatory B cells is VLA-4-dependent.

Authors:  Klaus Lehmann-Horn; Sharon A Sagan; Ryan C Winger; Collin M Spencer; Claude C A Bernard; Raymond A Sobel; Scott S Zamvil
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-09
View more
  1 in total

Review 1.  Immunoregulation by antibody secreting cells in inflammation, infection, and cancer.

Authors:  Shannon E McGettigan; Gudrun F Debes
Journal:  Immunol Rev       Date:  2021-06-17       Impact factor: 10.983

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.